Management of Genetic Syndromes / Edition 3

Management of Genetic Syndromes / Edition 3

ISBN-10:
0470191414
ISBN-13:
9780470191415
Pub. Date:
03/22/2010
Publisher:
Wiley
ISBN-10:
0470191414
ISBN-13:
9780470191415
Pub. Date:
03/22/2010
Publisher:
Wiley
Management of Genetic Syndromes / Edition 3

Management of Genetic Syndromes / Edition 3

Hardcover

$262.95 Current price is , Original price is $262.95. You
$262.95 
  • SHIP THIS ITEM
    Not Eligible for Free Shipping
  • PICK UP IN STORE
    Check Availability at Nearby Stores
  • SHIP THIS ITEM

    Temporarily Out of Stock Online

    Please check back later for updated availability.


Overview

The bestselling guide to the medical management of common genetic syndromes —now fully revised and expanded

A review in the American Journal of Medical Genetics heralded the first edition of Management of Genetic Syndromes as an "unparalleled collection of knowledge." Since publication of the first edition, improvements in the molecular diagnostic testing of genetic conditions have greatly facilitated the identification of affected individuals. This thorough revision of the critically acclaimed bestseller offers original insights into the medical management of sixty common genetic syndromes seen in children and adults, and incorporates new research findings and the latest advances in diagnosis and treatment of these disorders.

Expanded to cover five new syndromes, this comprehensive new edition also features updates of chapters from the previous editions. Each chapter is written by an expert with extensive direct professional experience with that disorder and incorporates thoroughly updated material on new genetic findings, consensus diagnostic criteria, and management strategies. Edited by two of the field's most highly esteemed experts, this landmark volume provides:

  • A precise reference of the physical manifestations of common genetic syndromes, clearly written for professionals and families

  • Extensive updates, particularly in sections on diagnostic criteria and diagnostic testing, pathogenesis, and management

  • A tried-and-tested, user-friendly format, with each chapter including information on incidence, etiology and pathogenesis, diagnostic criteria and testing, and differential diagnosis

  • Up-to-date and well-written summaries of the manifestations followed by comprehensive management guidelines, with specific advice on evaluation and treatment for each system affected, including references to original studies and reviews

  • A list of family support organizations and resources for professionals and families

Management of Genetic Syndromes, Third Edition is a premier source to guide family physicians, pediatricians, internists, medical geneticists, and genetic counselors in the clinical evaluation and treatment of syndromes. It is also the reference of choice for ancillary health professionals, educators, and families of affected individuals looking to understand appropriate guidelines for the management of these disorders.

From a review of the first edition:

"An unparalleled collection of knowledge . . . unique, offering a gold mine of information." —American Journal of Medical Genetics


Product Details

ISBN-13: 9780470191415
Publisher: Wiley
Publication date: 03/22/2010
Edition description: 3rd ed.
Pages: 984
Product dimensions: 8.80(w) x 11.00(h) x 1.90(d)

About the Author

Suzanne Cassidy, MD, is Clinical Professor of Pediatrics at University of California, San Francisco and at University of California, Irvine. She is a board-certified Medical Geneticist and Pediatrician who has focused on care of individuals with genetic syndromes throughout her 30-year academic and clinical career. She is devoted to educating medical geneticists, having served on the American Board of Medical Genetics and the founding Residency Review Committee for Medical Genetics, as well as directed genetics training programs in 4 institutions. She served on the board of directors of the American Society of Human Genetics and as a member of the Board of Scientific Counselors of National Center for Human Genome Research at NIH. She has been identified as one of 'America's Top Doctors'.

Judith E. Allanson, MD, is Chief of the Department of Genetics, and Professor of Pediatrics at the University of Ottawa.  She is a board-certified Medical Geneticist and Internist with longstanding interests in pattern recognition, syndrome identification and management.

Read an Excerpt

Management of Genetic Syndromes


John Wiley & Sons

Copyright © 2005 Wiley-Liss, Inc.
All right reserved.

ISBN: 0-471-30870-6


Chapter One

INTRODUCTION

Suzanne B. Cassidy Department of Pediatrics, Division of Human Genetics, University of California, Irvine, Orange, California

Judith E. Allanson Department of Pediatrics, University of Ottawa and Department of Genetics, Children's Hospital of Eastern Ontario, Ottawa, Canada

ORGANIZATION OF THIS BOOK

Each chapter of this book is dedicated to the diagnosis and management of a specific syndrome that is encountered with regularity in specialty programs and occasionally in primary care practice. The authors are acknowledged "experts" who have considerable personal experience in the management of the disorder. Each chapter thus contains unpublished information based on that experience and on the author's personal approach to management in addition to a review of published information. Each chapter format is similar, providing general information on incidence and inheritance, pathogenesis and etiology, diagnostic criteria and testing, and differential diagnosis. The myriad manifestations of each syndrome are presented system by system, with emphasis on the features, evaluation, management, and prognosis. The first two "systems" in each chapter are Growth and Feeding and Development and Behavior. After these, the systems relevant to the specific disorder arediscussed, usually in order of importance for that disorder. Every attempt has been made to include whatever is known about the disorder in adulthood. Each chapter concludes with a listing of family support organizations and some resources available to families and professionals in print and electronic formats. Photographs of physical findings important for diagnosis or management are provided. Selected references stressing management issues and citations of good review articles have been included.

This introductory chapter is designed to inform the reader about genetics-related terms used in this book, inheritance patterns, general methods for genetic testing, measurement methods, and the role of the medical geneticist and genetic counselor in the care of genetic disorders. It also provides some important references to additional resources of information about genetic disorders, differential diagnoses, genetic testing, and support organizations.

CATEGORIZATION OF DISORDERS

The descriptive language for patterns of anomalies is somewhat unique to the field of dysmorphology and deserves a brief review. The term syndrome is used to describe a broad error of morphogenesis in which the simultaneous presence of more than one malformation is known or assumed to be the result of a single etiology. Its use implies that the group of malformations and/or physical differences has been seen repeatedly in a fairly consistent and unique pattern. The initial definition of any syndrome occurs after the publication of several similar case reports. It becomes refined over time as newly described individuals suggest the inclusion of additional anomalies and the exclusion of others. Thus a syndrome comes to be defined by the coexistence of a small but variable number of "hallmark" anomalies, whereas several other features may be observed at lower frequencies. Even after a particular syndrome is well established, the inherent variability or rarity can make diagnosis difficult.

In a specific individual, one or more of the hallmark features of a disorder may be absent and yet the person is affected. It is important to stress that not all syndromes are associated with mental retardation. Generally, no one feature or anomaly is pathognomonic of a syndrome, and even experienced dysmorphologists may disagree about diagnosis. Often, the individual clinician will have had little direct experience of the syndrome. In this environment, the addition of objective methods of evaluation may be useful. Available techniques include direct measurement (anthropometry), standard photographs (photogrammetry), and radiologic assessment (cephalometry). Each method has advantages and disadvantages, and each has its proponents (for details, see Allanson, 1997).

The term sequence is used to designate a series of anomalies resulting from a cascade of events initiated by a single malformation, deformation, or disruption (Spranger et al., 1982). A well-known example is the Robin sequence in which the initiating event is micrognathia. The small mandible then precipitates glossoptosis (posterior and upward displacement of the tongue in the pharynx) with resultant incomplete fusion of the palatal shelves. The initiating event may be a malformation of the mandible or a deformation caused by in utero constraint and thus inhibiting normal growth of the mandible. The individual components of a sequence may well involve quite disparate parts of the body. For example, lower limb joint contractures and bilateral equinovarus deformity may be found in a child with a meningomyelocele.

An association is a nonrandom occurrence in two or more individuals of multiple anomalies not known to represent a sequence or syndrome (Spranger et al., 1982). These anomalies are found together more often than expected by chance alone, demonstrating a statistical relationship but not necessarily a known causal one. For example, the CHARGE association represents a simultaneous occurrence of two or more malformations that include congenital coloboma of the iris, choroid, or optic nerve, heart defects, atresia of choanae, mental and somatic retardation, male genital hypoplasia, and ear anomalies or deafness. An association has limited prognostic significance, and the degree of variability may pose diagnostic problems for the clinician. Most affected children will not have all the anomalies described, which makes establishment of minimal diagnostic criteria difficult. Recognition of an association is useful in that it can guide the clinician, after discovery of two or more component malformations, toward a directed search for the additional anomalies. Associations are generally sporadic within a family and have a low empirical recurrence risk. It is most important to remember that associations are diagnoses of exclusion. Any child with multiple anomalies affecting several systems, with or without growth and/or intellectual retardation, should first be assessed to rule out a specific syndrome diagnosis and, lacking such a diagnosis, should have chromosome analysis.

MEASUREMENTS

Selected measurements, with comparison to normal standards, may be helpful in confirming the subjective impression of an abnormality. Common craniofacial dimensions, which provide detail about facial shape and size, include head circumference, inner and outer canthal distances, ear length, position, and rotation. Evaluation of stature should include height (length), upper and lower body segment, arm span, hand length, palm length, and foot length. Normal standards for these and a wide variety of other standardized measurements can be found in the Handbook of Normal Physical Measurements (Hall et al., 1989), Growth References: Third Trimester to Adulthood (Saul et al., 1998), and Smith's Recognizable Patterns of Human Malformation (Jones, 1997); however, ethnic background, for which norms may vary, should be taken into consideration. Increasingly, standard curves are being developed for particular syndromes. Many syndrome-specific standards have been compiled (Saul et al., 1998).

The best way to document dysmorphic features is to photograph them. The prudent clinician will often adopt an attitude of "watchful waiting" if the diagnosis is not apparent at the first assessment (Aase, 1990). As children's facial and body features evolve with time, they may "grow into" a syndrome, and photographs provide serial documentation of these changes. There is great value to reassessment of the individual with multiple anomalies whose diagnosis is unclear because there is significant diagnostic yield (Hall et al., 1988). The "art" of dysmorphology is eloquently discussed by Aase (1990). Photographs also facilitate consultations with colleagues and consultants by providing objective evidence of the affected individual's physical findings. They can be compared with examples of other syndromes in photographic databases such as POSSUM and the London Dysmorphology Database (see below).

COMMON GENETIC TERMINOLOGY

With the recent rapid advances in human genetics has come a proliferation of terms with which many practitioners are unfamiliar. Therefore, a summary of the common terms relating to genes and chromosomes and the major inheritance patterns is in order.

Genes are the individual pieces of coding information that we inherit from our parents, the blueprint, as it were, for an organism. It is estimated that 30,000 to 40,000 genes are required to develop and "operate" a human being. Individual genes occur in pairs, one inherited from each parent. The balance of the expression of these genes is extremely delicate, with significant abnormality resulting when this balance is disturbed for some genes. Variant forms of the same gene are known as alleles, and variation can have no apparent phenotypic effect or major consequences, depending on the specific gene and many other factors. When a variant has minimal phenotypic effect, it is often called a polymorphism.

Some syndromes are caused by a permanent structural or sequence change (or mutation) in a single gene. Many gene mutations cause their adverse effects through deficient gene expression (and often subsequent protein deficiency), which is called haploinsufficiency. This is often the case when a mutation in a gene results in failure to produce the gene product, which can be a so-called null mutation or a protein truncation mutation. However, other mutations cause their adverse effects by interfering with a process or causing a new adverse effect, and such mutations are called dominant negative mutations. The latter is often the result when a structurally abnormal protein is formed. Mutation results in alteration of the sequence and/or length of the bases composing the gene code. Such alterations may result in the substitution of one amino acid for another (a missense mutation) in the production of a sequence that does not correspond to the code for an amino acid (a nonsense mutation) or in a code that tells the translation machinery to stop prematurely. An unusual form of mutation that is present in a number of neurogenetic disorders, such as fragile X syndrome, myotonic dystrophy, Huntington disease, and the spinocerebellar ataxias, among others, is the so-called triplet repeat expansion. Some genes contain within them a string of three bases repeated a number of times. For example, CGG is repeated up to 50 times in the normal fragile X gene (CGGCGGCGG ...). Under certain circumstances, this number becomes amplified, resulting in an increase in the number of such repeated triplets of bases. Thus, in individuals who are affected with fragile X syndrome, an X-linked cause of mental retardation, there may be hundreds of such repeated triplets. This triplet repeat expansion interferes with the normal function of the gene, causing abnormality (in this case, mental retardation). In fragile X syndrome, the gene actually becomes inactivated if the expansion exceeds a certain number of repeats. Please see Chapter 22 for a more detailed explanation of this type of mutation.

The nomenclature for genes and gene products (proteins) can be quite confusing, despite the best efforts toward a logical approach. The names of genes are often put in italics, and these may represent an abbreviation of the name of the disorder, the name of the protein, or a function of the protein or the gene. For example, the gene causing neurofibromatosis type 1 is called NF1, and the protein is named neurofibromin, whereas the gene for Angelman syndrome, UBE3A, is named for its protein product, which is one of a family of ubiquitin-protein ligases (enzymes that are part of the protein degradation process). The gene responsible for fragile X syndrome is called FMR1 (fragile X-linked mental retardation 1), and the protein is called FMRP (fragile X-linked mental retardation protein). Information on the genes is included in the chapters for those who are interested, but aside from genetic testing purposes, it is not critical to know the nomenclature to understand and treat the disorder.

Human genes are "packaged" into 46 chromosomes, of which normally 23 chromosomes are transmitted to the offspring in the egg from the mother and 23 in the sperm from the father. One pair of chromosomes, the sex chromosomes, differs between males and females. Females have two copies of the X chromosome, whereas males have one copy, the second sex chromosome being the Y chromosome with a largely different set of genes. The remaining 22 pairs, the autosomes, do not differ between males and females. The autosomes are numbered in a standard way from largest to smallest. The location of a specific gene on a chromosome is called the locus (the plural is loci). Some of the syndromes described in this book are caused by the presence of an entire extra chromosome (e.g., Down syndrome, Klinefelter syndrome) or duplication of a segment of a chromosome (e.g., some cases of Beckwith-Wiedemann syndrome). Others occur because of loss of all (e.g., Turner syndrome) or part (e.g., some cases of Prader-Willi syndrome) of a chromosome.

PATTERNS OF INHERITANCE

An alteration in a gene can be dominant or recessive. A dominant gene mutation only needs to be present in one member of the gene pair to have a clinically evident impact. Any individual with an autosomal dominant gene mutation will have a 1 in 2 chance to pass it on to his or her child, male or female, with each pregnancy. An example is achondroplasia. In achondroplasia, the affected child frequently has two average-stature parents, indicating that the mutation occurred in the egg or sperm that was involved in the conception. This is referred to as a new mutation or a de novo mutation. Rarely, an apparently normal couple will have more than one child with the same apparently new mutation in an autosomal dominant gene. This suggests that the mutation is present in some of the cells of the germ line (gonads) but not in most other cells of the body of one parent. This is known as germ line (or gonadal) mosaicism.

Continues...


Excerpted from Management of Genetic Syndromes Copyright © 2005 by Wiley-Liss, Inc.. Excerpted by permission.
All rights reserved. No part of this excerpt may be reproduced or reprinted without permission in writing from the publisher.
Excerpts are provided by Dial-A-Book Inc. solely for the personal use of visitors to this web site.

Table of Contents

Foreword to the Third Edition.

Foreword to the Second Edition.

Foreword to the First Edition.

Preface.

Contributors.

1 Introduction (Suzanne B. Cassidy and Judith E. Allanson).

2 Aarskog Syndrome (Roger E. Stevenson).

3 Achrondroplasia (Richard M. Pauli).

4 Alagille Syndrome (Binita M. Kamath and Ian D. Krantz).

5 Albinism: Ocular and Oculocutaneous Albinism and Hermansky-Pudlak Syndrome (Richard A. King and C. Gail Summers).

6 Angelman Syndrome (Charles A. Williams and Aditi Dagli).

7 Arthrogryposis (Judith G. Hall).

8 ATR-X (α-Thalassemia Mental Retardation-X-Linked) (Richard J. Gibbons).

9 Bardet-Biedl Syndrome (Anne M. Slavotinek).

10 Beckwith-Wiedemann Syndrome and Hemihyperplasia (Rosanna Weksberg, Cheryl Shuman, and Bruce Beckwith).

11 Cardio-Facio-Cutaneous Syndrome (Maria Inês Kavamura and Giovanni Neri).

12 CHARGE Syndrome (Christine A. Oley).

13 Coffin-Lowry Syndrome (Alasdair G.W. Hunter).

14 Cohen Syndrome (Kate Chandler and Jill Clayton-Smith).

15 Cornelia de Lange Syndrome (David R. Fitzpatrick and Antonie D. Kline).

16 Costello Syndrome (Bronwyn Kerr, Karen W. Gripp and Angela E. Lin).

17 Craniosynostosis Syndromes (Karen W. Gripp and Elaine H. Zackai).

18 Deletion 1p36 Syndrome (Agatino Battaglia).

19 Deletion 4p: Wolf-Hirschhorn Syndrome (Agatino Battaglia).

20 Deletion 22q11.2 (Velo-Cardio-Facial Syndrome/DiGeorge Syndrome) (Donna M. McDonald-McGinn, Taisa Kohut and Elaine H. Zackai).

21 Deletion 22q13 Syndrome: Phelan-McDermid Syndrome (Mary C. Phelan, Gail A. Stapleton and R. Curtis Rogers).

22 Denys-Drash and Frasier Syndromes (Carol L. Clericuzio).

23 Down Syndrome (Alasdair G.W. Hunter).

24 Ehlers-Danlos Syndromes (Brad T. Tinkle and Carrie L. Atzinger).

25 Fetal Alcohol Syndrome and Fetal Alcohol Spectrum Disorder (Albert E. Chudley and Sally E. Longstaffe).

26 Fetal Anticonvulsant Syndrome (H. Eugene Hoyme, Renata C. Gallagher, and Kerry Kingham).

27 Fragile X Syndrome and Premutation-Associated Disorders (Randi J. Hagerman).

28 Gorlin Syndrome (Nevoid Basal Cell Carcinoma Syndrome) (Peter Farndon).

29 Hereditary Hemorrhagic Telangiectasia (Mary E.M. Porteous and Jonathan N. Berg).

30 Holoprosencephaly (Andrea L. Gropman and Maximilian Muenke).

31 Incontinentia Pigmenti (Dian Donnai).

32 Kabuki Syndrome (Sarah Dugan and Louanne Hudgins).

33 Klinefelter Syndrome (Jeannie Visootsak, John M. Graham Jr., Carole Samango-Sprouse, Ronald Swerdloff, and Joe Leigh Simpson).

34 Marfan Syndrome (Uta Francke).

35 Mowat-Wilson Syndrome (David Mowat and Meredith Wilson).

36 Myotonic Dystrophy Type I (Christine E.M. de Die-Smulders, Frans G.I. Jennekens and Carin G. Faber).

37 Neurofibromatosis Type 1 (David Viskochil).

38 Noonan Syndrome (Judith E. Allanson).

39 Oculo-Auriculo-Vertebral Spectrum (Koenraad Devriendt, Luc de Smet and Ingele Casteels).

40 Osteogenesis Imperfecta (Joan C. Marini).

41 Pallister-Hall and Greig Cephalopolysyndactyly Syndromes (Leslie G. Biesecker).

42 Prader-Willi Syndrome (Suzanne B. Cassidy and Shawn E. McCandless).

43 Proteus Syndrome (Leslie G. Biesecker).

44 PTEN Hamartoma Tumor Syndromes (Emily Edelman and Charis Eng).

45 Rett Syndrome (Eric E. Smeets and Connie T.R.M. Schrander-Stumpel).

46 Robin Sequence (Howard M. Saal).

47 Rubinstein-Taybi Syndrome (Raoul C.M. Hennekam).

48 Russell-Silver Syndrome (Howard M. Saal).

49 Smith-Lemli-Opitz Syndrome (Christopher Cunniff).

50 Smith-Magenis Syndrome (Ann C.M. Smith and Andrea Gropman).

51 Sotos Syndrome (Trevor R.P. Cole).

52 Stickler Syndrome (Clair A. Francomano).

53 Treacher Collins Syndrome and Related Disorders (Marilyn C. Jones).

54 Trisomy 18 and Trisomy 13 Syndromes (John C. Carey).

55 Tuberous Sclerosis Complex (Hope Northrup, Michael J. Gambello, Kit Sing Au, and Mary Kay Koenig).

56 Turner Syndrome (Marsha L. Davenport).

57 Vater/Vacterl Association (Bryan D. Hall).

58 von Hippel-Lindau Syndrome (R. Neil Schimke and Debra L. Collins).

59 WAGR Syndrome (Carol L. Clericuzio).

60 Williams Syndrome (Colleen A. Morris).

INDEX.

What People are Saying About This

From the Publisher

I found the book to be a well-edited collection of the management of some common and some quite rare congenital and genetic disorders. The authors of the chapters have been well chosen and have done a marvelous job of reviewing the disorders themselves and bringing the reader up to date on what if anything can be done for them. All-in-all it is to be recommended for all clinical geneticists and genetic counselors as an invaluable resource.

Cassidy and Allanson have assembled a talented group of authors to address the more common genetic disorders. The chapters are extremely well organized and each emphasizes not only diagnostic techniques and differential diagnosis, but also patient management. The generalist will find a wealth of practical information readily available and accessible. The clinical geneticist will discover and rediscover valuable "pearls" within this text. —Edward R.B. McCabe, Department of Pediatrics, Mattel Children's Hospital at UCLA

From the B&N Reads Blog

Customer Reviews